Literature DB >> 19623582

Radiation responses of cancer stem cells.

Erina Vlashi1, William H McBride, Frank Pajonk.   

Abstract

Recent experimental evidence indicates that many solid cancers have a hierarchical organization structure with a subpopulation of cancer stem cells (CSCs). The ability to identify CSCs prospectively now allows for testing the responses of CSCs to treatment modalities like radiation therapy. Initial studies have found CSCs in glioma and breast cancer relatively resistant to ionizing radiation and possible mechanisms behind this resistance have been explored. This review summarizes the landmark publications in this young field with an emphasis on the radiation responses of CSCs. The existence of CSCs in solid cancers place restrictions on the interpretation of many radiobiological observations, while explaining others. The fact that these cells may be a relatively quiescent subpopulation that are metabolically distinct from the other cells in the tumor has implications for both imaging and therapy of cancer. This is particularly true for biological targeting of cancer for enhanced radiotherapeutic benefit, which must consider whether the unique properties of this subpopulation allow it to avoid such therapies. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19623582      PMCID: PMC2865474          DOI: 10.1002/jcb.22275

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  40 in total

1.  Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.

Authors:  Marion Scharpfenecker; Jacqueline J C M Kruse; Debbie Sprong; Nicola S Russell; Peter Ten Dijke; Fiona A Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-01       Impact factor: 7.038

2.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

3.  PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.

Authors:  Dolores Hambardzumyan; Oren J Becher; Marc K Rosenblum; Pier Paolo Pandolfi; Katia Manova-Todorova; Eric C Holland
Journal:  Genes Dev       Date:  2008-02-15       Impact factor: 11.361

Review 4.  "Destemming" cancer stem cells.

Authors:  Richard P Hill; Roberto Perris
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

5.  Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

Authors:  Roberto Pallini; Lucia Ricci-Vitiani; Giuseppe Luigi Banna; Michele Signore; Dario Lombardi; Matilde Todaro; Giorgio Stassi; Maurizio Martini; Giulio Maira; Luigi Maria Larocca; Ruggero De Maria
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

6.  Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors.

Authors:  Robert W Cho; Xinhao Wang; Maximilian Diehn; Kerby Shedden; Grace Y Chen; Gavin Sherlock; Austin Gurney; John Lewicki; Michael F Clarke
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

7.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

8.  Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model.

Authors:  Sheila Alcantara Llaguno; Jian Chen; Chang-Hyuk Kwon; Erica L Jackson; Yanjiao Li; Dennis K Burns; Arturo Alvarez-Buylla; Luis F Parada
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

9.  Cancer induction by restriction of oncogene expression to the stem cell compartment.

Authors:  María Pérez-Caro; César Cobaleda; Inés González-Herrero; Carolina Vicente-Dueñas; Camino Bermejo-Rodríguez; Margarita Sánchez-Beato; Alberto Orfao; Belén Pintado; Teresa Flores; Manuel Sánchez-Martín; Rafael Jiménez; Miguel A Piris; Isidro Sánchez-García
Journal:  EMBO J       Date:  2008-11-27       Impact factor: 11.598

10.  Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor.

Authors:  Shih-Hwa Chiou; Chung-Lan Kao; Yi-Wei Chen; Chien-Shu Chien; Shih-Chieh Hung; Jeng-Fan Lo; Yann-Jang Chen; Hung-Hai Ku; Ming-Ta Hsu; Tai-Tong Wong
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

View more
  33 in total

1.  CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.

Authors:  Joseph G Pressey; Marilyn C Haas; Christine S Pressey; Virginia M Kelly; Jacqueline N Parker; G Yancey Gillespie; Gregory K Friedman
Journal:  Pediatr Blood Cancer       Date:  2012-03-09       Impact factor: 3.167

Review 2.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

3.  Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.

Authors:  Lorenz Kadletz; Klaus Aumayr; Gregor Heiduschka; Sven Schneider; Elisabeth Enzenhofer; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-28       Impact factor: 2.503

4.  Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.

Authors:  Le Zhang; Liang Xu; Fengchun Zhang; Erina Vlashi
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

Review 5.  The therapeutic promise of the cancer stem cell concept.

Authors:  Natasha Y Frank; Tobias Schatton; Markus H Frank
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

6.  Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.

Authors:  Chann Lagadec; Erina Vlashi; Lorenza Della Donna; Yonghong Meng; Carmen Dekmezian; Kwanghee Kim; Frank Pajonk
Journal:  Breast Cancer Res       Date:  2010-02-16       Impact factor: 6.466

7.  Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.

Authors:  Ryan Morrison; Stephen M Schleicher; Yunguang Sun; Kenneth J Niermann; Sungjune Kim; Daniel E Spratt; Christine H Chung; Bo Lu
Journal:  J Oncol       Date:  2010-10-12       Impact factor: 4.375

8.  New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.

Authors:  Galina I Botchkina; Edison S Zuniga; Manisha Das; Yuan Wang; Hichao Wang; Shu Zhu; Anne G Savitt; Rebecca A Rowehl; Yan Leyfman; Jingfang Ju; Kenneth Shroyer; Iwao Ojima
Journal:  Mol Cancer       Date:  2010-07-14       Impact factor: 27.401

9.  The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.

Authors:  Loredana G Marcu; David Marcu
Journal:  Cell Prolif       Date:  2017-08-30       Impact factor: 6.831

10.  Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.

Authors:  Kshama R Jaiswal; Hong-Wu Xin; Andrew Anderson; Gordon Wiegand; Bo Kim; Tyler Miller; Danielle Hari; Satyajit Ray; Tomotake Koizumi; Udo Rudloff; Snorri S Thorgeirsson; Itzhak Avital
Journal:  Stem Cell Res       Date:  2012-08-19       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.